Consensus Nkarta, Inc.

Equities

NKTX

US65487U1088

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
7.4 ^USD	-1.73%		+7.71%	+12.12%

03-26	Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating	MT
03-25	HC Wainwright Adjusts Price Target on Nkarta to $22 From $20, Keeps Buy Rating	MT

Evolution of the average Target Price on Nkarta, Inc.

Price target over the last 5 years

History of analyst recommendation changes

604d3ce747c40db01a206371346303d.njtXwIcut4HuHN3CdXUxBclAEUdBoxKPFoM0v-5sDZY.2BYiq7BKwNSeJOqKJDdCYKQZRx4x8F7hRMhB8JcPUvXbXTKT0kT-wNd1hA~96fadfbdf3981a2a9c5f101c5095f775

Analyst Recommendations on Nkarta, Inc.

Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating	03-26	MT
HC Wainwright Adjusts Price Target on Nkarta to $22 From $20, Keeps Buy Rating	03-25	MT
Mizuho Securities Lowers Price Target on Nkarta to $25 From $31, Keeps Buy Rating	03-22	MT
Mizuho Securities Cuts Price Target on Nkarta to $25 From $31, Maintains Buy Rating	03-22	MT
HC Wainwright Adjusts Nkarta's Price Target to $20 From $22, Keeps Buy Rating	03-22	MT
Raymond James Downgrades Nkarta to Outperform From Strong Buy, Price Target is $16	03-22	MT
Mizuho Securities Adjusts Price Target on Nkarta to $31 From $9 as Lupus Nephritis Program Gets Attention, Keeps Buy Rating	03-04	MT
Mizuho Securities Cuts Nkarta's Price Target to $9 From $15, Maintains Buy Rating	11-16	MT
HC Wainwright Adjusts Price Target on Nkarta to $10 From $16, Keeps Buy Rating	23-10-18	MT
Raymond James Upgrades Nkarta to Strong Buy From Outperform, Price Target is $13	23-10-18	MT
Mizuho Adjusts Nkarta's Price Target to $15 From $26, Keeps Buy Rating	23-08-14	MT
Raymond James Adjusts Price Target on Nkarta to $13 From $32, Maintains Outperform Rating	23-06-28	MT
Needham Cuts Price Target on Nkarta to $19 From $26, Maintains Buy Rating	23-06-27	MT
Stifel Trims Price Target on Nkarta to $18 From $21, Maintains Buy Rating	23-05-12	MT
HC Wainwright Adjusts Price Target on Nkarta to $30 From $34, Maintains Buy Rating	23-03-17	MT
Oppenheimer Downgrades Nkarta to Perform From Outperform, Removes $26 Price Target	22-12-22	MT
Mizuho Slashes Price Target on Nkarta to $26 From $81, Affirms Buy Rating	22-11-15	MT
Oppenheimer Adjusts Nkarta Price Target to $36 From $50, Maintains Outperform Rating	22-11-10	MT
Canaccord Genuity Starts Nkarta at Buy with $25 Price Target	22-10-10	MT
Cantor Fitzgerald Adjusts Nkarta's Price Target to $38 From $60, Reiterates Overweight Rating	22-08-12	MT
Needham Initiates Nkarta at Buy with $26 Price Target	22-07-28	MT
SVB Securities Initiates Coverage on Nkarta With Outperform Rating, $30 Price Target	22-07-18	MT
Raymond James Adjusts Nkarta's Price Target to $32 From $17, Keeps Outperform Rating	22-04-26	MT
HC Wainwright Adjusts Nkarta Price Target to $36 From $25, Maintains Buy Rating	22-04-25	MT
Stifel Adjusts Nkarta's Price Target to $45 From $71, Reiterates Buy Rating	22-03-18	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.4 USD

Average target price

19.25 USD

Spread / Average Target

+160.14%

High Price Target

25 USD

Spread / Highest target

+237.84%

Low Price Target

15 USD

Spread / Lowest Target

+102.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nkarta, Inc.

Canaccord Genuity
HC Wainwright
Mizuho Securities
Raymond James
Needham & Co.
Stifel Nicolaus
Oppenheimer
Cantor Fitzgerald
SVB Securities LLC
William Blair & Co.
SMBC Nikko

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar